Stockreport

Silence Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF Net loss: UK£45.3m (loss widened by 4.7% from FY 2023). UK£0.98 loss per share. NasdaqGM:SLN Earnings and Revenue Growth March 1st 2025 All figures shown in the c [Read more]